Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Breast and Gynecologic Cancer Research Group

Programs and Projects

Ovarian Cancer Prevention Clinical Trials


Ongoing Phase I/II Prevention Trials Funded and Monitored by the Breast and Gynecologic Cancer Research Group (BGCRG)

Principal Investigator Funding Mechanism Title of Award Chemopreventive Agent
Robert Park, MD
Gynecologic Oncology Group
Master Agreement Fenretinide as Chemoprevention in Ovarian Carcinoma 4-HPR
Molly Brewer, MD
University of Arizona
Master Agreement A Multicenter Randomized Double-Blinded Trial for Chemoprevention of Ovarian Cancer: Modulation of Biomarkers and Spectral Properties using Contrast Enhanced Ultrasound In High-risk Women using Fenretinide (4-HPR)
NCT00098800
4-HPR Placebo


** indicates studies that are open to accrual

Back to top